Screener
Zevra Therapeutics, Inc. ZVRA Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Zevra Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.
The source filing: Zevra Therapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001434647-26-000068
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $145,321 | $62,406 |
| Investments, current | 76,249 | 128,605 |
| Accounts and other receivables | 22,489 | 23,258 |
| Prepaid expenses and other current assets | 4,794 | 6,998 |
| Inventories, current | 2,449 | 1,740 |
| Total current assets | 251,302 | 223,007 |
ITEM 1.FINANCIAL STATEMENTS
FAQ
- What is Zevra Therapeutics, Inc.'s short-term investments?
- Zevra Therapeutics, Inc. (ZVRA) reported short-term investments of $76.25M in Q2 2026.
- How has Zevra Therapeutics, Inc.'s short-term investments changed year-over-year?
- Zevra Therapeutics, Inc.'s short-term investments decreased by 50.8% year-over-year, from $154.9M to $76.25M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.
Ask your AI about Zevra Therapeutics, Inc.'s short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude